Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Myfembree fda approval?Aimovig price france?Patent loss eculizumab miasthenia?Biosynthetic production histamine patent application?Erivedge licensing deal?
See the DrugPatentWatch profile for Myfembree
Myfembree’s generic name is relugolix.
Myfembree is a combination product: it contains relugolix plus estradiol (as estradiol 1.0 mg) and norethindrone acetate (as 0.5 mg).
Because some sources use the drug name developers market for the active drug (relugolix), while others describe the full combination as relugolix + estradiol + norethindrone acetate.
For the most up-to-date information on generic and patent status, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Myfembree :